Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
Background. For the treatment of visceral leishmaniasis in Bangladesh, single dose liposomal amphotericin B (ambisome) is supposed to be the safest and most effective treatment. Specific needs for application and storage raise questions about feasibility of its implementation and acceptance by patie...
Saved in:
Main Authors: | Eva-Maria Maintz, Mahbub Hassan, M. Mamun Huda, Debashis Ghosh, Md. Shakhawat Hossain, Abdul Alim, Axel Kroeger, Byron Arana, Dinesh Mondal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/676817 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
by: Megha Raj Banjara, et al.
Published: (2012-01-01) -
Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B
by: Shauna McQuarrie, et al.
Published: (2015-01-01) -
Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01) -
Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
by: Demet Toprak, et al.
Published: (2015-01-01) -
Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
by: Sunny Garg, et al.
Published: (2012-01-01)